1.1200
+0.0900
+(8.74%)
As of 2:30:09 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 598,642 | 20 |
| Sales | 94,298 | 1 |
| Net Shares Purchased (Sold) | 504,344 | 21 |
| Total Insider Shares Held | 4.67k | -- |
| % Net Shares Purchased (Sold) | -100.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CLIMACO JOHN M Chief Executive Officer | Purchase at price 0.30 per share. | Direct | 50,000 | Feb 1, 2024 |
| DOWNS CHRISTOPHER Chief Financial Officer | Purchase at price 0.30 per share. | Direct | 20,000 | Feb 1, 2024 |
| EVANS CARL ANTHONY Director | Purchase at price 0.30 per share. | Direct | 10,000 | Feb 1, 2024 |
| GUMULKA JERZY Director | Purchase at price 0.30 per share. | Direct | 10,000 | Feb 1, 2024 |
| DOWNS CHRISTOPHER Chief Financial Officer | Purchase at price 1.27 per share. | Direct | 34,177 | Aug 22, 2023 |
| CLIMACO JOHN M Chief Executive Officer | Purchase at price 1.80 per share. | Direct | 4,944 | Aug 16, 2023 |
| CLIMACO JOHN M Chief Executive Officer | -- | Direct | -- | Apr 28, 2023 |
| DOWNS CHRISTOPHER Chief Financial Officer | -- | Direct | -- | Apr 28, 2023 |
| GUMULKA JERZY Director | Purchase at price 1.70 per share. | Direct | 4,250 | Apr 19, 2023 |
| DOWNS CHRISTOPHER Chief Financial Officer | Purchase at price 3.20 per share. | Direct | 9,920 | Apr 17, 2023 |
| CLIMACO JOHN M Chief Executive Officer | Purchase at price 0.69 per share. | Direct | 10,408 | Apr 12, 2023 |
| GUMULKA JERZY Director | Purchase at price 0.74 per share. | Direct | 5,308 | Apr 10, 2023 |
| PRIEBE WALDEMAR PH.D. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.04 - 2.47 per share. | Indirect | 133,114 | Mar 28, 2023 |
Related Tickers
VRPX Virpax Pharmaceuticals, Inc.
0.6695
-45.12%
ADTX Aditxt, Inc.
3.1400
-4.56%
CDT Conduit Pharmaceuticals Inc.
0.6117
+3.68%
DRMA Dermata Therapeutics, Inc.
0.8028
-0.89%
CERO CERo Therapeutics Holdings, Inc.
0.7900
+12.06%
CDIO Cardio Diagnostics Holdings, Inc.
0.3460
+9.39%
WINT Windtree Therapeutics, Inc.
1.3376
+2.89%
OCEA Ocean Biomedical, Inc.
0.0420
+6.60%
ELAB PMGC Holdings Inc.
3.8600
+7.22%
APTO Aptose Biosciences Inc.
1.7100
0.00%